Francisco Altamirano1, Gabriele G Schiattarella1,2, Kristin M French1, Soo Young Kim1, Felipe Engelberger3, Sergii Kyrychenko1, Elisa Villalobos1, Dan Tong1, Jay W Schneider1, Cesar A Ramirez-Sarmiento3, Sergio Lavandero1,4,5, Thomas G Gillette1, Joseph A Hill1,6. 1. Department of Internal Medicine, Cardiology Division (F.A., G.G.S., K.M.F., S.Y.K., S.K., E.V., D.T., J.W.S., S.L., T.G.G., J.A.H.), University of Texas Southwestern Medical Center, Dallas. 2. Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy (G.G.S.). 3. Institute for Biological and Medical Engineering, Schools of Engineering, Medicine, and Biological Sciences, Pontificia Universidad Catolica de Chile, Santiago, Chile (F.E., C.A.R.S.). 4. Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas & Facultad de Medicina, Universidad de Chile, Santiago, Chile (S.L.). 5. Corporación Centro de Estudios Científicos de las Enfermedades Crónicas (CECEC), Santiago, Chile (S.L.). 6. Department of Molecular Biology (J.A.H.), University of Texas Southwestern Medical Center, Dallas.
Abstract
BACKGROUND: Polycystin-1 (PC1) is a transmembrane protein originally identified in autosomal dominant polycystic kidney disease where it regulates the calcium-permeant cation channel polycystin-2. Autosomal dominant polycystic kidney disease patients develop renal failure, hypertension, left ventricular hypertrophy, and diastolic dysfunction, among other cardiovascular disorders. These individuals harbor PC1 loss-of-function mutations in their cardiomyocytes, but the functional consequences are unknown. PC1 is ubiquitously expressed, and its experimental ablation in cardiomyocyte-specific knockout mice reduces contractile function. Here, we set out to determine the pathophysiological role of PC1 in cardiomyocytes. METHODS: Wild-type and cardiomyocyte-specific PC1 knockout mice were analyzed by echocardiography. Excitation-contraction coupling was assessed in isolated cardiomyocytes and human embryonic stem cell-derived cardiomyocytes, and functional consequences were explored in heterologous expression systems. Protein-protein interactions were analyzed biochemically and by means of ab initio calculations. RESULTS: PC1 ablation reduced action potential duration in cardiomyocytes, decreased Ca2+ transients, and myocyte contractility. PC1-deficient cardiomyocytes manifested a reduction in sarcoendoplasmic reticulum Ca2+ stores attributable to a reduced action potential duration and sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) activity. An increase in outward K+ currents decreased action potential duration in cardiomyocytes lacking PC1. Overexpression of full-length PC1 in HEK293 cells significantly reduced the current density of heterologously expressed Kv4.3, Kv1.5 and Kv2.1 potassium channels. PC1 C terminus inhibited Kv4.3 currents to the same degree as full-length PC1. Additionally, PC1 coimmunoprecipitated with Kv4.3, and a modeled PC1 C-terminal structure suggested the existence of 2 docking sites for PC1 within the N terminus of Kv4.3, supporting a physical interaction. Finally, a naturally occurring human mutant PC1R4228X manifested no suppressive effects on Kv4.3 channel activity. CONCLUSIONS: Our findings uncover a role for PC1 in regulating multiple Kv channels, governing membrane repolarization and alterations in SERCA activity that reduce cardiomyocyte contractility.
BACKGROUND:Polycystin-1 (PC1) is a transmembrane protein originally identified in autosomal dominant polycystic kidney disease where it regulates the calcium-permeant cation channel polycystin-2. Autosomal dominant polycystic kidney diseasepatients develop renal failure, hypertension, left ventricular hypertrophy, and diastolic dysfunction, among other cardiovascular disorders. These individuals harbor PC1 loss-of-function mutations in their cardiomyocytes, but the functional consequences are unknown. PC1 is ubiquitously expressed, and its experimental ablation in cardiomyocyte-specific knockout mice reduces contractile function. Here, we set out to determine the pathophysiological role of PC1 in cardiomyocytes. METHODS: Wild-type and cardiomyocyte-specific PC1 knockout mice were analyzed by echocardiography. Excitation-contraction coupling was assessed in isolated cardiomyocytes and human embryonic stem cell-derived cardiomyocytes, and functional consequences were explored in heterologous expression systems. Protein-protein interactions were analyzed biochemically and by means of ab initio calculations. RESULTS:PC1 ablation reduced action potential duration in cardiomyocytes, decreased Ca2+ transients, and myocyte contractility. PC1-deficient cardiomyocytes manifested a reduction in sarcoendoplasmic reticulum Ca2+ stores attributable to a reduced action potential duration and sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) activity. An increase in outward K+ currents decreased action potential duration in cardiomyocytes lacking PC1. Overexpression of full-length PC1 in HEK293 cells significantly reduced the current density of heterologously expressed Kv4.3, Kv1.5 and Kv2.1potassium channels. PC1 C terminus inhibited Kv4.3 currents to the same degree as full-length PC1. Additionally, PC1 coimmunoprecipitated with Kv4.3, and a modeled PC1 C-terminal structure suggested the existence of 2 docking sites for PC1 within the N terminus of Kv4.3, supporting a physical interaction. Finally, a naturally occurring human mutant PC1R4228X manifested no suppressive effects on Kv4.3 channel activity. CONCLUSIONS: Our findings uncover a role for PC1 in regulating multiple Kv channels, governing membrane repolarization and alterations in SERCA activity that reduce cardiomyocyte contractility.
Authors: Rajan Sah; Rafael J Ramirez; Gavin Y Oudit; Dominica Gidrewicz; Maria G Trivieri; Carsten Zobel; Peter H Backx Journal: J Physiol Date: 2003-01-01 Impact factor: 5.182
Authors: K Hanaoka; F Qian; A Boletta; A K Bhunia; K Piontek; L Tsiokas; V P Sukhatme; W B Guggino; G G Germino Journal: Nature Date: 2000 Dec 21-28 Impact factor: 49.962
Authors: Roger Kaprielian; Rajan Sah; Tin Nguyen; Alan D Wickenden; Peter H Backx Journal: Am J Physiol Heart Circ Physiol Date: 2002-09 Impact factor: 4.733
Authors: Elisabeth DiNello; Elisa Bovo; Paula Thuo; Thomas G Martin; Jonathan A Kirk; Aleksey V Zima; Quan Cao; Ivana Y Kuo Journal: Am J Physiol Heart Circ Physiol Date: 2020-09-18 Impact factor: 4.733
Authors: Karla M Márquez-Nogueras; Virdjinija Vuchkovska; Elisabeth DiNello; Sara Osorio-Valencia; Ivana Y Kuo Journal: Am J Physiol Cell Physiol Date: 2022-06-08 Impact factor: 5.282
Authors: Marciana V Sousa; Andressa G Amaral; Jessica A Freitas; Gilson M Murata; Elieser H Watanabe; Bruno E Balbo; Marcelo D Tavares; Renato A Hortegal; Camila Rocon; Leandro E Souza; Maria C Irigoyen; Vera M Salemi; Luiz F Onuchic Journal: Sci Rep Date: 2021-07-14 Impact factor: 4.379
Authors: Soo Young Kim; Xin Zhang; Gabriele G Schiattarella; Francisco Altamirano; Thais A R Ramos; Kristin M French; Nan Jiang; Pamela A Szweda; Bret M Evers; Herman I May; Xiang Luo; Hongliang Li; Luke I Szweda; Vinicius Maracaja-Coutinho; Sergio Lavandero; Thomas G Gillette; Joseph A Hill Journal: Circulation Date: 2020-10-28 Impact factor: 39.918
Authors: Diem Hong Tran; Herman I May; Qinfeng Li; Xiang Luo; Jian Huang; Guangyu Zhang; Erica Niewold; Xiaoding Wang; Thomas G Gillette; Yingfeng Deng; Zhao V Wang Journal: Nat Commun Date: 2020-04-14 Impact factor: 14.919